Document is current
Any future updates will be listed below
-
Authors
Anitua, Eduardo
Padilla, Sabino
Prado, Roberto
Tierno, Roberto
Hamdan Alkhraisat, Mohammad
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 20 March 2026
First Online: 21 April 2026
Declarations
:
: Not applicable. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
: Not applicable.
: The authors declare the following competing financial interests: Eduardo Anitua is the Scientific Director of BTI Biotechnology Institute, and Mohammad Hamdan Alkhraisat, Roberto Prado, Roberto Tierno, and Sabino Padilla are scientists at BTI Biotechnology Institute, a biotechnological company that investigates in the fields of oral implantology and PRGF-Endoret ® technology.
